103 related articles for article (PubMed ID: 6192289)
41. Surgery in the management of stage III germinal cell tumors. Observations on the M.D. Anderson Hospital experience, 1971-1979.
Logothetis CJ; Samuels ML
Cancer Treat Rev; 1984 Mar; 11(1):27-37. PubMed ID: 6203643
[TBL] [Abstract][Full Text] [Related]
42. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
[TBL] [Abstract][Full Text] [Related]
43. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
44. Effects of multiple-drug chemotherapy (cis-diammine-dichloroplatinum, bleomycin, and vinblastine) on the maturation of retroperitoneal lymph node metastases of nonseminomatous germ cell tumors of the testis. No evidence for De Novo induction of differentiation.
Oosterhuis JW; Suurmeyer AJ; Sleyfer DT; Koops HS; Oldhoff J; Fleuren G
Cancer; 1983 Feb; 51(3):408-16. PubMed ID: 6185202
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
Culine S; Theodore C; Court BH; Perrin JL; Droz JP
Br J Urol; 1997 Feb; 79(2):258-62. PubMed ID: 9052479
[TBL] [Abstract][Full Text] [Related]
46. Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasms.
Bukowski RM; Smith GW; Montie JE
Urology; 1988 May; 31(5):403-7. PubMed ID: 2452507
[TBL] [Abstract][Full Text] [Related]
47. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.
Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z
J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216
[TBL] [Abstract][Full Text] [Related]
48. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
Toner GC; Panicek DM; Heelan RT; Geller NL; Lin SY; Bajorin D; Motzer RJ; Scher HI; Herr HW; Morse MJ
J Clin Oncol; 1990 Oct; 8(10):1683-94. PubMed ID: 2170590
[TBL] [Abstract][Full Text] [Related]
49. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.
Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J
J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771
[TBL] [Abstract][Full Text] [Related]
50. Non-seminomatous germ cell testicular tumours: residual masses after chemotherapy.
Levitt MD; Reynolds PM; Sheiner HJ; Byrne MJ
Br J Surg; 1985 Jan; 72(1):19-22. PubMed ID: 2578300
[TBL] [Abstract][Full Text] [Related]
51. [Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
Taue R; Harada A; Katto K; Yamamoto Y; Kishimoto T; Nakatuji Y; Tanimoto S; Oka N; Izaki H; Fukumori T; Takahashi M; Nishitani M; Kanayama HO
Hinyokika Kiyo; 2006 Apr; 52(4):293-6. PubMed ID: 16686359
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy of extragonadal germ cell tumors.
Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
[TBL] [Abstract][Full Text] [Related]
53. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
54. Primary embryonal carcinoma of the retroperitoneum.
Ohkubo N; Ogihara T; Miura T; Soejima K; Iyori S; Akasaka Y; Tashiro M
Intern Med; 1993 Apr; 32(4):295-7. PubMed ID: 7689366
[TBL] [Abstract][Full Text] [Related]
55. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
56. Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patients.
McLeod DG; Taylor HG; Skoog SJ; Knight RD; Dawson NA; Waxman JA
Cancer; 1988 Mar; 61(6):1187-91. PubMed ID: 2449276
[TBL] [Abstract][Full Text] [Related]
57. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction.
Einhorn LH; Williams SD; Mandelbaum I; Donohue JP
Cancer; 1981 Aug; 48(4):904-8. PubMed ID: 6168361
[TBL] [Abstract][Full Text] [Related]
58. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
59. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
J Clin Oncol; 2005 Sep; 23(25):6149-56. PubMed ID: 16135481
[TBL] [Abstract][Full Text] [Related]
60. Neo-adjuvant chemotherapy with delayed orchiectomy in patients with advanced germ cell testicular cancer.
Ondrus D; Hornák M; Matoska J
Neoplasma; 1993; 40(3):189-92. PubMed ID: 7688871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
